(Q61969931)
Statements
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes (English)
0 references
November 2013
0 references
March 2014
0 references
48
0 references
18 year
0 references
64 year
0 references